Center for Financial Planning’s Asensus Surgical, Inc. ASXC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-16
Closed -$6 614
2024
Q2
$6 Hold
16
﹤0.01% 583
2024
Q1
$4 Hold
16
﹤0.01% 607
2023
Q4
$6 Hold
16
﹤0.01% 524
2023
Q3
$5 Hold
16
﹤0.01% 517
2023
Q2
$9 Hold
16
﹤0.01% 571
2023
Q1
$11 Hold
16
﹤0.01% 536
2022
Q4
$6 Hold
16
﹤0.01% 542
2022
Q3
$0 Hold
16
﹤0.01% 694
2022
Q2
$0 Hold
16
﹤0.01% 570
2022
Q1
$0 Hold
16
﹤0.01% 578
2021
Q4
$0 Hold
16
﹤0.01% 574
2021
Q3
$0 Hold
16
﹤0.01% 535
2021
Q2
$0 Hold
16
﹤0.01% 555
2021
Q1
$0 Hold
16
﹤0.01% 542
2020
Q4
$0 Hold
16
﹤0.01% 493
2020
Q3
$0 Hold
16
﹤0.01% 474
2020
Q2
$0 Hold
16
﹤0.01% 598
2020
Q1
$0 Hold
16
﹤0.01% 613
2019
Q4
$0 Buy
+16
New +$56 ﹤0.01% 466

Other funds holding ASXC

Center for Financial Planning's ASXC Position: Q3 2024 in Review

Center for Financial Planning sold out of Asensus Surgical, Inc. (ASXC) in Q3 2024, closing a stake of 16 shares — an estimated $6 sold.

Center for Financial Planning first reported a position in ASXC in Q4 2019 and held it in 19 quarters. The position peaked at $11 in Q1 2023. 1 fund tracked by Wall St. Rank holds ASXC as of Q3 2024.

  • Center for Financial Planning reported no remaining Asensus Surgical, Inc. position as of Q3 2024 after selling out during the quarter.
  • Center for Financial Planning sold 16 Asensus Surgical, Inc. shares in Q3 2024, an estimated $6.
  • Center for Financial Planning first reported a position in Asensus Surgical, Inc. in Q4 2019 and held it in 19 quarters.
  • Center for Financial Planning's Asensus Surgical, Inc. position peaked at $11 in Q1 2023.
  • 1 fund tracked by Wall St. Rank held Asensus Surgical, Inc. as of Q3 2024.

Based on Center for Financial Planning's 13F filing for Q3 2024, filed 16 Oct 2024.